Kutatási jelek – Signal Engine

• Amputation and Chemotherapy for Osteosarcoma — Osteosarcoma
• Clinical trial: Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06541444) — Acute myeloid leukemia
• Exploratory Study of NK510 Cell Therapy in the Treatment of Recurrent and Refractory Advanced Gastric Cancer and Colorectal Cancer — Colorectal cancer
• Waldenstrom Macroglobulinemia: Background, Pathophysiology, Etiology — Waldenstrom macroglobulinemia
• Blood Cancer United Pilot Clinical Trial Grants — Waldenstrom macroglobulinemia
• Blood test to rule out esophageal cancer — Esophageal cancer
• New NRG Oncology Trial for High-Risk Locally Advanced Cervical Cancer Launching Soon! — Cervical cancer
• P‑Sam for Adenoid Cystic Carcinoma – Phase 2 Clinical Trial — Adenoid cystic carcinoma
• New study reveals a hidden risk after cervical cancer — Cervical cancer
• Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias — Lymphoma
• Top Colorectal Cancer Trials to Watch at ESMO 2025 — Colorectal cancer
• NSCLC: three trials to keep an eye on — NSCLC
• New, 'off-the-shelf' immunotherapy shows promise for treating high-risk childhood leukemia — Leukemia
• Genomic Analysis Distinguishes Thyroid Cancers Caused by Radiation — Thyroid cancer
• Insight (S2414) for Early Stage NSCLC (Non-Small Cell Lung Cancer) — NSCLC
• Surveillance After Treatment of Adenoid Cystic Carcinoma of the Head and Neck: Review of Institutional Outcomes and Proposed Surveillance Imaging Protocol — Head and neck squamous cell carcinoma
• 2025 guideline for the management of peritoneal mesothelioma — Malignant pleural mesothelioma
• BNT327 SCLC — SCLC
• Patterns of treatment utilization and sequencing across lines of therapy in Waldenström macroglobulinemia (WM): Real‑world evidence from the United States — Waldenstrom macroglobulinemia
• Study uncovers molecular "switch" behind chemoresistance in blood cancer — Leukemia